Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Archived Tissue
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Cancer Prognosis
100%
RT-PCR Method
100%
Quantitative PCR
18%
Human Papillomavirus Types
18%
Expression Profiling
18%
Expression Profile
18%
Transcriptional Activity
18%
Human Genes
9%
MRNA Expression
9%
Patient Outcomes
9%
In Situ Hybridization
9%
Disease Outcome
9%
Head-and-neck Cancer
9%
Genotype
9%
Cervical Cancer
9%
HPV16
9%
Surrogate Marker
9%
Gene Signature
9%
PCR Method
9%
Prognostic Biomarker
9%
Fixed Tissue
9%
Detection Method
9%
Disease Prediction
9%
RNA Detection
9%
Protein Expression Signature
9%
Papillomavirus Infections
9%
Real-time RT-PCR
9%
Oropharyngeal Tumor
9%
E7 Expression
9%
E7 Oncogene
9%
E6 Oncogene
9%
RNA Fluorescence in Situ Hybridization (RNA-FISH)
9%
Medicine and Dentistry
Reverse Transcription Polymerase Chain Reaction
100%
Wart Virus
100%
Oropharynx Carcinoma
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
P16
25%
Oropharynx Squamous Cell Carcinoma
25%
In Situ Hybridization
16%
Biological Marker
8%
Prevalence
8%
Protein Expression
8%
Cervical Cancer
8%
Oncogene
8%
Human Papillomavirus Type 16
8%
Disease Marker
8%
Head and Neck Cancer
8%
Oropharynx Tumor
8%
Papillomavirus Infection
8%
Messenger RNA
8%
Diseases
8%
Immunology and Microbiology
Wart Virus
100%
Reverse Transcription Polymerase Chain Reaction
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
23%
Squamous Cell
23%
In Situ Hybridization
15%
Ribonucleic Acid
15%
Prevalence
7%
Protein Expression
7%
Human Papillomavirus Type 16
7%
Neck
7%
Prognostic Biomarker
7%
Oncogene
7%
Infection
7%
Biochemistry, Genetics and Molecular Biology
Reverse Transcription Polymerase Chain Reaction
100%
Wart Virus
100%
P16
23%
Quantitative Reverse Transcription Polymerase Chain Reaction
23%
RNA
15%
In Situ Hybridization
15%
Protein Expression
7%
Prevalence
7%
Oncogene
7%
Human Papillomavirus Type 16
7%
Messenger RNA
7%